Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 84,333	$ 110,643
Restricted cash	1,798	1,804
Investments	252,221	278,344
Trade receivables	60,586	56,950
Inventory, net	29,781	28,683
Prepaid expenses and other current assets	18,381	19,542
Total current assets	447,100	495,966
Property and equipment, net	7,831	7,910
Other assets	12,961	13,084
Total assets	467,892	516,960
Liabilities and Stockholders’ Deficit
Accounts payable	11,910	20,893
Accrued expenses	79,249	102,882
Operating lease liabilities	1,098	1,058
Finance lease liabilities	1,642	1,590
Royalty financing obligations	26,022	23,565
Total current liabilities	119,921	149,988
Operating lease liabilities	8,596	8,390
Finance lease liabilities	2,506	2,845
Royalty financing obligations	504,552	508,034
Secured term loan	308,484	303,231
Stockholders’ deficit:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding at March 31, 2024 and December 31, 2023	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 206,347 at March 31, 2024 and 205,771 at December 31, 2023	2,063	2,058
Additional paid-in capital	1,237,537	1,222,236
Accumulated other comprehensive income	771	1,337
Accumulated deficit	(1,716,538)	(1,681,159)
Total stockholders’ deficit	(476,167)	(455,528)
Total liabilities and stockholders’ deficit	$ 467,892	$ 516,960